EUTM file information

000072710

ASPIVENIN


March 31, 1996

Trademark Summary

The trademark ASPIVENIN was filed by DOMES PHARMA SC, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on January 18, 1998, and received one opposition filed on March 23, 1998 by Bayer Aktiengesellschaft on Likelihood of confusion. the opponent was represented by Pastor, Helmut and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued March 23, 1998

The application was filed in French, and French was also language of all opposition proceedings (English was selected as the second language).

Two renewals of the trademark were recorded, one on June 5, 2006, and the other one on April 20, 2016.

Change of name and professional address of the trademark registration was recorded on October 18, 2000. A transfer of the trademark registration was recorded on November 14, 2001. A transfer of the trademark registration was recorded on November 14, 2001. Change of name and address of the trademark registration was recorded on March 24, 2006. Change of name and address of the trademark registration was recorded on June 17, 2007. A transfer of the trademark registration was recorded on July 8, 2007. Change of name and professional address of the trademark registration was recorded on February 28, 2011. Appointment and Replacement of representative of the trademark registration was recorded on March 22, 2012. Appointment and Replacement of representative of the trademark registration was recorded on January 29, 2015. A transfer of the trademark registration was recorded on July 20, 2015. A transfer of the trademark registration was recorded on May 11, 2021.

The application claimed as seniority of the Federal Republic of Germany trademark null registered on July 10, 1984 which was accepted by the office.


Goods And Services

  • The mark was filed in class 10 with Pumps for medical use.